AOBIM Internal Medicine study materials
AOBIM Internal Medicine study resources

New Hyperglycemia in a Hospitalized Patient on Steroids

AOBIM Internal Medicine · Put your knowledge to work in context.

All case studies

New Hyperglycemia in a Hospitalized Patient on Steroids

A 64-year-old woman with no prior diagnosis of diabetes is admitted with a COPD exacerbation and started on prednisone 40 mg daily plus antibiotics and nebulized bronchodilators. On hospital day 2, her point-of-care glucose is 310 mg/dL, and repeat is 285 mg/dL. She is eating poorly and reports no polyuria. Her HbA1c is 6.1%, and she has no prior history of diabetes. The nurse asks whether to start a sliding-scale insulin regimen or 'just watch it' because 'it's probably from the steroids.'

1. How should you interpret the hyperglycemia, and what is the appropriate initial management?

Read the worked answer

Steroid-induced hyperglycemia is common, especially with prednisone, and can occur even in patients without diabetes; the elevated glucose is real and warrants treatment. An HbA1c of 6.1% suggests she is not chronically diabetic, but the acute hyperglycemia (310 mg/dL) is clinically significant and can worsen outcomes. She should be started on a basal-bolus or scheduled insulin regimen rather than relying solely on sliding-scale correction, especially since she is eating poorly and may have variable intake. Sliding-scale alone is often inadequate and can lead to wide swings. Monitor glucose frequently, and consider that steroid-induced hyperglycemia often peaks in the afternoon/evening.

2. What are the key safety considerations given her poor oral intake and COPD?

Read the worked answer

With poor intake, a fixed basal insulin dose risks hypoglycemia, so use a conservative basal dose and prandial insulin only with meals, or a correction-based approach with close monitoring. Avoid sulfonylureas, which can cause prolonged hypoglycemia. Monitor for hypoglycemia, especially if intake remains low. Also consider that beta-agonists and steroids both raise glucose, and that infection can contribute. Reassess glucose control as steroids are tapered, since insulin requirements will fall. Coordinate with nursing for glucose checks before meals and at bedtime, and educate the patient about symptoms of hypoglycemia.

3. What should the discharge plan include regarding glucose management?

Read the worked answer

Because the hyperglycemia is likely steroid-related and her HbA1c is normal, she may not need long-term diabetes therapy. However, she needs a plan: monitor glucose, taper insulin as steroids taper, and arrange follow-up with primary care to reassess after discharge. Provide education about sick-day management and when to seek care. If she remains on steroids at discharge, she may need a temporary insulin regimen with clear instructions. Document the reasoning and avoid both over-treatment (labeling her diabetic unnecessarily) and under-treatment (missing ongoing hyperglycemia).